Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

IGC Pharma (IGC) Leases (2020 - 2025)

IGC Pharma has reported Leases over the past 6 years, most recently at $13000.0 for Q3 2025.

  • Quarterly Leases fell 91.93% to $13000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $13000.0 through Sep 2025, down 91.93% year-over-year, with the annual reading at $98000.0 for FY2025, 50.51% down from the prior year.
  • Leases was $13000.0 for Q3 2025 at IGC Pharma, down from $16000.0 in the prior quarter.
  • Over five years, Leases peaked at $538000.0 in Q2 2021 and troughed at $13000.0 in Q3 2025.
  • The 5-year median for Leases is $295000.0 (2023), against an average of $292105.3.
  • Year-over-year, Leases fell 2.71% in 2021 and then tumbled 91.93% in 2025.
  • A 5-year view of Leases shows it stood at $482000.0 in 2021, then dropped by 25.93% to $357000.0 in 2022, then plummeted by 36.41% to $227000.0 in 2023, then crashed by 43.17% to $129000.0 in 2024, then crashed by 89.92% to $13000.0 in 2025.
  • Per Business Quant, the three most recent readings for IGC's Leases are $13000.0 (Q3 2025), $16000.0 (Q2 2025), and $98000.0 (Q1 2025).